BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 8690871)

  • 1. [Fetal and neonatal immune thrombocytopenias].
    Neuhart D; Dreyfus M; Baldauf JJ; Maloisel F; Ritter J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(2):206-11. PubMed ID: 8690871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmune thrombocytopenia of the fetus and the newborn.
    Kaplan C
    Blood Rev; 2002 Mar; 16(1):69-72. PubMed ID: 11914000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal thrombocytopenia. Predicting neonatal thrombocytopenia with cordocentesis.
    Berry SM; Leonardi MR; Wolfe HM; Dombrowski MP; Lanouette JM; Cotton DB
    J Reprod Med; 1997 May; 42(5):276-80. PubMed ID: 9172117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fetal-neonatal thrombocytopenia of immunologic origin: current aspects].
    Kaplan C; Morel-Kopp MC; Forestier F; Dreyfus M; Daffos F; Tchernia G
    Pathol Biol (Paris); 1994 Oct; 42(8):783-9. PubMed ID: 7724251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic thrombocytopenic purpura in pregnancy.
    Sainio S; Joutsi L; Järvenpää AL; Kekomäki R; Koistinen E; Riikonen S; Teramo K
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):272-7. PubMed ID: 9539271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal management of the thrombocytopenias.
    Menell JS; Bussel JB
    Clin Perinatol; 1994 Sep; 21(3):591-614. PubMed ID: 7982336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet disorders in pregnancy: implications for mother and fetus.
    Paidas MJ; Haut MJ; Lockwood CJ
    Mt Sinai J Med; 1994 Oct; 61(5):389-403. PubMed ID: 7799975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital posthemorrhagic hydrocephalus: a case of fetomaternal alloimmune thrombocytopenia.
    Póvoa AM; Ramalho C; Machado AP; Matias A; Montenegro N
    Fetal Diagn Ther; 2007; 22(5):321-4. PubMed ID: 17556816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal diagnosis and management of fetomaternal alloimmune thrombocytopenia.
    Dickinson JE; Marshall LR; Phillips JM; Barr AL
    Am J Perinatol; 1995 Sep; 12(5):333-5. PubMed ID: 8540936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune thrombocytopenia and pregnancy].
    Sandoval Rodríguez T
    Ginecol Obstet Mex; 1995 Jun; 63():246-9. PubMed ID: 7642150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia in the foetus and the newborn: diagnosis and therapy.
    Kaplan C
    Transfus Clin Biol; 2001 Jun; 8(3):311-4. PubMed ID: 11499984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura.
    Samuels P; Bussel JB; Braitman LE; Tomaski A; Druzin ML; Mennuti MT; Cines DB
    N Engl J Med; 1990 Jul; 323(4):229-35. PubMed ID: 2366833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis of fetal thrombocytopenia].
    Póka R; Katona N; Juhász B
    Orv Hetil; 1997 Feb; 138(8):485-6. PubMed ID: 9139253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HPA-9bw (Maxa) fetomaternal alloimmunization, a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families.
    Kaplan C; Porcelijn L; Vanlieferinghen P; Julien E; Bianchi F; Martageix C; Bertrand G; Jallu V
    Transfusion; 2005 Nov; 45(11):1799-803. PubMed ID: 16271107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia.
    Radder CM; Brand A; Kanhai HH
    Am J Obstet Gynecol; 2001 Sep; 185(3):683-8. PubMed ID: 11568798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous umbilical blood sampling in pregnant women with thrombocytopenia. Apropos of 35 cases].
    Razafintsalama T; Coiffic J; Godin O; Lassel L; Chevrant-Breton O; Poulain P
    J Gynecol Obstet Biol Reprod (Paris); 2000 Apr; 29(2):176-84. PubMed ID: 10790630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia.
    Berkowitz RL; Kolb EA; McFarland JG; Wissert M; Primani A; Lesser M; Bussel JB
    Obstet Gynecol; 2006 Jan; 107(1):91-6. PubMed ID: 16394045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.
    Kroll H; Yates J; Santoso S
    Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal/neonatal allo-immune thrombocytopenias: the unsolved questions].
    Kaplan C
    Transfus Clin Biol; 2005 Jun; 12(2):131-4. PubMed ID: 15950890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia.
    Bertrand G; Martageix C; Jallu V; Vitry F; Kaplan C
    J Thromb Haemost; 2006 Mar; 4(3):628-37. PubMed ID: 16460445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.